Document Type
Article
Language
eng
Format of Original
12 p.
Publication Date
10-2009
Publisher
Lippincott Williams & Wilkins, Inc.
Source Publication
Journal of Cardiovascular Pharmacology
Source ISSN
0160-2446
Original Item ID
doi: 10.1097/FJC.0b013e3181b2b842
Abstract
Mitochondria are damaged by cardiac ischemia/reperfusion (I/R) injury but can contribute to cardioprotection. We tested if hyperkalemic cardioplegia (CP) and lidocaine (LID) differently modulate mitochondrial (m) bioenergetics and protect hearts against I/R injury. Guinea pig hearts (n = 71) were perfused with Krebs Ringer's solution before perfusion for 1 minute just before ischemia with either CP (16 mM K+) or LID (1 mM) or Krebs Ringer's (control, 4 mM K+). The 1-minute perfusion period assured treatment during ischemia but not on reperfusion. Cardiac function, NADH, FAD, m[Ca2+], and superoxide (reactive oxygen species) were assessed at baseline, during the 1-minute perfusion, and continuously during I/R. During the brief perfusion before ischemia, CP and LID decreased reactive oxygen species and increased NADH without changing m[Ca2+]. Additionally, CP decreased FAD. During ischemia, NADH was higher and reactive oxygen species was lower after CP and LID, whereas m[Ca2+] was lower only after LID. On reperfusion, NADH and FAD were more normalized, and m[Ca2+] and reactive oxygen species remained lower after CP and LID. Better functional recovery and smaller infarct size after CP and LID were accompanied by better mitochondrial function. These results suggest that mitochondria may be implicated, directly or indirectly, in protection by CP and LID against I/R injury.
Recommended Citation
Aldakkak, Mohammed; Stowe, David F.; Lesnefsky, Edward J.; Heisner, James S.; Chen, Qun; and Camara, Amadou K.S., "Modulation of Mitochondrial Bioenergetics in the Isolated Guinea Pig Beating Heart by Potassium and Lidocaine Cardioplegia: Implications for Cardioprotection" (2009). Biomedical Engineering Faculty Research and Publications. 268.
https://epublications.marquette.edu/bioengin_fac/268
Comments
Accepted version. Journal of Cardiovascular Pharmacology, Vol. 54, No. 4 (October 2009): 298-309. DOI. © 2009 Lippincott Williams & Wilkins, Inc. Used with permission.